MEDTRONIC PUERTO RICO OPERATIONS CO. PUMP MMT-1711KL 640G V4.10 BK SF MM; PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR
|
Back to Search Results |
|
Model Number MMT-1711KL |
Device Problem
Insufficient Flow or Under Infusion (2182)
|
Patient Problems
Dehydration (1807); Hyperglycemia (1905); Nausea (1970); Dizziness (2194); Diabetic Ketoacidosis (2364)
|
Event Date 04/11/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.The insulin pump involved in this event is the 640g insulin infusion pump, which is not marketed in the united states.However, the device is similar to the paradigm real-time insulin infusion pump, which is marketed in the united states.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Information received by medtronic indicated that the customer alleged that the insulin pump was under delivering because they had unexpected high blood glucose values with no alerts regarding occlusion.Customer was dispatched through emergency medical services and hospitalized due to hyperglycemia on (b)(6) 2022.Customers blood glucose value was 26.5 mmol/l at the time on incident.The customer¿s current blood glucose value was 13.5 mmol/l.The customer experienced symptoms such as diabetic ketoacidosis, nausea, dizziness and dehydrated due to high blood glucose value.The customer treated high blood glucose with insulin drip.No further patient complications were reported.The insulin pump will not be returned for analysis.
|
|
Manufacturer Narrative
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Information related to the summary has been updated and provided with this report in section b5.
|
|
Event Description
|
Customer reported that one hour after evening meal with correction bolus, she had high blood glucose.She treated with pump and injections.As her blood glucose did not decrease, she called her doctor who recommended that she call the paramedics and ask for hospitalization.Customer called the paramedics and was hospitalized on (b)(6), 2022 at 11:30pm for high blood glucose and diabetic ketoacidosis.Customer had dizziness, nausea, and dehydration.Customer tested positive for ketones.Customer was treated with insulin drip in the hospital.There was no alert for occlusion.Customer alleged under delivery.Customer did not get any assistance in programming her pump.Pump was used.Sensor was not used.
|
|
Search Alerts/Recalls
|
|
|